Cap insulin at $35 a month.

Greg Stanton · Arizona · Democratic

policy impact 0.86 specificity 0.90 extraction confidence 99%

Contest this claim

Occurrences

Evidence

Stanton's official House health-care page says he supports "capping insulin at just $35 a month" as part of his health agenda.

Shows Stanton publicly maintained the insulin-cap promise as an active policy goal.

partial later_term

Health Care | Congressman Greg Stanton
primary · model gpt-5.4-mini · confidence 86%

Contest this evidence item

After House passage of the Inflation Reduction Act, Stanton said Congress had delivered on promises to cut drug costs and that he had pushed to let Medicare use negotiating power to lower prescription drug prices since his first day in Congress.

Official statement shows Stanton actively advanced the broader drug-cost effort that led to the insulin cap in the IRA.

partial later_term A for effort

Stanton: Inflation Reduction Act Delivers on Promises to Arizona Seniors, Families | Congressman Greg Stanton
secondary · model gpt-5.4-mini · confidence 82%

Contest this evidence item

The House roll call for H.R. 5376 shows Rep. Greg Stanton (AZ) voted Yea on the Build Back Better Act vote that preceded the final Inflation Reduction Act package.

Confirms Stanton supported the legislation vehicle that contained the insulin-cost provisions.

partial later_term A for effort

Office of the Clerk, U.S. House of Representatives Roll Call 385
secondary · model gpt-5.4-mini · confidence 90%

Contest this evidence item

CMS says the Inflation Reduction Act ensures people with Medicare pay no more than $35 for a month’s supply for each covered insulin product under Medicare prescription drug coverage, Traditional Medicare, or Medicare Advantage.

The enacted federal policy did create a $35 insulin cap, but only for Medicare-covered insulin products, not universally.

partial later_term

Anniversary of the Inflation Reduction Act: Update on CMS Implementation
secondary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

Assessments

partial same_term A for effort

The federal outcome during Stanton's 2021-2023 House term was a real $35 monthly insulin cap, enacted through the Inflation Reduction Act in August 2022, but it applied to Medicare-covered insulin rather than all insulin users. Stanton was in office at the time and supported the relevant Democratic drug-cost legislation, so he gets candidate credit for materially advancing the partial outcome, but the broader promise was not fully delivered universally.

provider codex_cli · model gpt-5.5 · confidence 90%